Clinical trials: Clinical Pharmacists
Renal Impairments, Chronic Kidney Disease
Evaluation of Clinical Pharmacy Services and Drug Use in Renal Impairment.
Clinical pharmacy services aim to optimise medication use, enhance patient outcomes, and reduce the risk of drug-related harm through patient-centred pharmaceutical care.
- Conditions
- Renal Impairments, Chronic Kidney Disease, Acute Kidney Disease, Medication Errors
- Trial name
- RECAP-Rx (NCT07241494)
- Testing
- Clinical Pharmacist-Led Pharmaceutical Care Service and Renal Dose Adjustment, Education for renal adjusments
- Where
- Turkey (Türkiye)
- Volunteers
- 160 people
- Sponsor
- Istanbul University - Cerrahpasa
Diabetes Mellitus, Type 2, Diabetic Nephropathies
Impact of AI-Based Breath Ammonia Kidney Function Results on Clinical Pharmacist Medication Recommendations
This retrospective study evaluates whether providing clinicians with artificial intelligence (AI)-based kidney function results from a breath ammonia test can improve the quality of medication recommendations made by clinical…
- Trial name
- NCT07888855
- Where
- China
- Volunteers
- 380 people
- Sponsor
- Shanghai Pudong Hospital
Drug Related Problem
Incidence and Risk Factor of Drug Related Problem Detected in Inpatient
Drug Related Problem (DRP) is defined as an event that may potentially affect the health outcomes in the patients. DRPs can occur at all stages of the medication usage process starting from prescribing to dispensing stage.
- Trial name
- DRPINPAT (NCT03476733)
- Testing
- Detection of drug related problem in inpatient
- Where
- France
- Volunteers
- 20,000 people
- Sponsor
- University Hospital, Montpellier
Hypertension
Utilizing Consumer Health Informatics to Support Management of Hypertension by Clinical Pharmacists in Primary Care
The purpose of this research study is to test the feasibility, acceptability, and preliminary effectiveness of the use of a mobile pharmacist-led intervention that incorporates home BP monitoring and medication reminders with…
- Trial name
- NCT02898584
- Testing
- BP Track
- Where
- United States
- Volunteers
- 16 people
- Sponsor
- University of Michigan
Type 2 Diabetes
Rural Area Pharmacist Intervention for Diabetes
The goal of the project is to inform the system leaders regarding the feasibility and utility of having an embedded telehealth-based clinical pharmacist at rural primary care practices for supportive disease management of…
- Trial name
- NCT05761886
- Testing
- telehealth-based clinical pharmacy intervention
- Where
- United States
- Volunteers
- 87 people
- Sponsor
- Wake Forest University Health Sciences
Diabetes, Type2diabetes
Effect of a Pharmacist-led, Collaborative Practice on Clinical Outcomes in Persons with Diabetes
Diabetes is a complex chronic illness known for its high prevalence (11.3% in the United States), significant healthcare burdens in terms of cost and management, and high mortality rate (seventh leading cause of death in the…
- Trial name
- NCT05995262
- Testing
- Chart Review
- Where
- United States
- Volunteers
- 100 people
- Sponsor
- Methodist Health System
Medication Reconciliation
Clinical Pharmacists in the Emergency Department
The purpose of this study is to investigate the effect of implementing clinical pharmacists in the Emergency Department Team at Randers Regional Hospital.
- Trial name
- NCT02223676
- Testing
- Clinical pharmacists conduct medication history
- Where
- Denmark
- Volunteers
- 448 people
- Sponsor
- Randers Regional Hospital
Vaccination
Study of the Impact of an Intervention Performed by a Clinical Pharmacist on Patients at Risk of Pneumococcal Infection at the End of Hospitalization
In France, Streptococcus pneumoniae is the leading agent involved in community-acquired bacterial pneumopathies and bacterial meningitis. The frequency of these infections is increasing in at-risk subjects.
- Trial name
- IP-VAC (NCT04734925)
- Where
- France
- Volunteers
- 167 people
- Sponsor
- Centre Hospitalier Universitaire de Nīmes
Diabetes Mellitus, Cardiovascular Diseases
Pharmacist-led Group Medical Visits to Help With Diabetes Management
This is a multi-site open label randomized controlled study of patients with type 2 diabetes undergoing pharmacist-led group medical visits that include education by a multi-disciplinary personnel, behavioral modification and…
- Trial name
- MEDIC-1 (NCT00554671)
- Testing
- Algorithm driven medication titration, Monitoring, Group support
- Where
- 3 sites in United States
- Volunteers
- 250 people
- Sponsor
- VA Office of Research and Development
Frailty, Emergency Department Visit
Association Between Geriatric Frailty and Medication Related Problems in the Emergency Department to Help Clinical Pharmacists Prioritise Patients
The healthcare systems are under increasing pressure due to a rise in emergency consultations, staff shortages, an ageing population and rising costs.
- Conditions
- Frailty, Emergency Department Visit, Elderly, Drug Drug Interaction
- Trial name
- DISARMED (NCT07282379)
- Testing
- Pharmaceutical analysis based on the Electronic Patient Record
- Where
- Switzerland
- Volunteers
- 300 people
- Sponsor
- Pharmacie des Hopitaux de l'Est Lemanique
Non-Alcoholic Fatty Liver Disease
Efficacy of Phosphatidylcholine in NAFLD
This study evaluates efficacy of Phosphatidylcholine in addition to life style modification and patient health education by clinical Pharmacist in the Management of Non Alcoholic Fatty Liver NAFLD.
- Trial name
- NCT04411862
- Testing
- Phosphatidyl Choline, Lifestyle modification
- Volunteers
- 100 people
- Sponsor
- Nehal Abou Seada
Stroke
An Evaluation of Clinical Pharmacist-led Intervention on Clinical Outcomes in Patients With Ischemic Stroke
Clinical pharmacy specialists are in an ideal position to assist medical teams in the management of patients with ischemic stroke.
- Trial name
- NCT01876667
- Testing
- Intervention (CPCRS) Group
- Where
- United States
- Volunteers
- 141 people
- Sponsor
- Kaiser Permanente
Clinical Pharmacists, Electronic Medical Record
Relationship Between the Clinical Pharmacist & Antibiotic Use by Using the Electronic Program
A retrospective cohort study to explore the association between clinical pharmacists' interventions and antibiotic consumption through the use of the medical electronic reports and to identify mortality and cost savings in…
- Trial name
- NCT05002647
- Testing
- NO intervention
- Where
- Egypt
- Volunteers
- 2,601 people
- Sponsor
- Alexandria University
Type 2 Diabetes, Hypertension
Impact of Clinical Pharmacist-Led Intervention on Management of Diabetic Hypertensive Patients in Eastern Nepal
Diabetic-Hypertensives are at a higher risk of premature microvascular and macrovascular complications than diabetes alone. Proper lifestyle management, diet, disease monitoring, and medication adherence is essential in achieving…
- Trial name
- NCT05707481
- Testing
- Clinical Pharmacist-Led Educational Intervention
- Where
- Nepal
- Volunteers
- 92 people
- Sponsor
- Chettinad Academy of Research and Education (Deemed to be University)
Coronary Heart Disease
Pharmaceutical Follow-up of Coronary Heart Disease (CHD) Patients
Objectives To explore the impact of a clinical pharmacist-led 12 month lasting follow-up program for patients with established coronary heart disease (CHD) discharged from the North Norway University Hospital.
- Trial name
- NCT01115608
- Testing
- Pharmacist follow-up
- Where
- Norway
- Volunteers
- 102 people
- Sponsor
- Hospital Pharmacy of North Norway Trust
Ambulatory Care Sensitive Conditions
Impact of Pharmacist-led Care Navigation Mediated by Digital Health Tools on Hospital Readmissions
Hospitalizations for Primary Care-Sensitive Conditions (PCSCs) are potentially avoidable hospital admissions that may be prevented when Primary Health Care provides effective and timely care through prevention, early diagnosis…
- Trial name
- NCT07789353
- Testing
- Pharmacist-led teleconsultations
- Where
- Brazil
- Volunteers
- 3,220 people
- Sponsor
- Hospital de Clinicas de Porto Alegre
Adverse Drug Events
Drug-Related Problems : Focus on Age and Diabetes
Drug-Related Problems (DRP) are a variety of events or circumstances that can interfere with the expected results of a treatment.
- Trial name
- DRP-AD (NCT04692220)
- Testing
- Detection of Adverse Drug Events or Drug-Related Problems
- Where
- France
- Volunteers
- 27,000 people
- Sponsor
- University Hospital, Montpellier
Epilepsy
Impact of Pharmaceutical Interviews on the Medication Adherence of Epileptic Patients
Many studies have reported a disparity in medication adherence among epileptic patients. In this population, Medication Possession Ratio (MPR) is an index of medication adherence.
- Trial name
- EPIPHARM (NCT04876820)
- Testing
- Pharmacist intervention, Standard of care
- Where
- France
- Volunteers
- 51 people
- Sponsor
- University Hospital, Lille
Chronic Heart Failure
The Role of Clinical Pharmacist in Management of DDIs in CHF Patients
Drug-drug interactions (DDIs) are common in patients with chronic heart failure (CHF) and their incidence increases with the number of drugs that the patients are prescribed for treatment of their condition.
- Trial name
- NCT01855165
- Testing
- Advice on DDIs
- Where
- Slovenia
- Volunteers
- 60 people
- Sponsor
- The University Clinic of Pulmonary and Allergic Diseases Golnik
Heart Failure With Reduced Ejection Fraction, Heart Failure; With Decompensation
Improving Knowledge in Heart Failure Inpatient With Therapeutic Education
The objective is to evaluate the impact of a pharmacist-led therapeutic education intervention on the knowledge of hospitalized heart failure patients.
- Conditions
- Heart Failure With Reduced Ejection Fraction, Heart Failure; With Decompensation, Pharmacist-Patient Relations, Medication Adherence
- Trial name
- EDUC-IC (NCT05751772)
- Testing
- Patient therapeutic education
- Where
- Switzerland
- Volunteers
- 38 people
- Sponsor
- University Hospital, Geneva